Aljohani, A. I., Toss, M. S., Kurozumi, S., Joseph, C., Aleskandarany, M. A., Miligy, I. M., . . . Rakha, E. A. (2019). The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer. Breast Cancer Res Treat.
Chicago Stili AlıntıAljohani, Abrar I., et al. "The Prognostic Significance of Wild-type Isocitrate Dehydrogenase 2 (IDH2) in Breast Cancer." Breast Cancer Res Treat 2019.
MLA AlıntıAljohani, Abrar I., et al. "The Prognostic Significance of Wild-type Isocitrate Dehydrogenase 2 (IDH2) in Breast Cancer." Breast Cancer Res Treat 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..